Announced
Completed
Novo Holdings led a $109m Series A round in Sidera Bio.
Synopsis
Novo Holdings, a holding and investment company, led a $109m Series A round in Sidera Bio, a company focused on unlocking the potential of human genetics to develop transformative medicines for patients, with participation from Forbion, RA Capital Healthcare Fund and Gilde Healthcare.
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
Claim DealAll rights reserved. Copyright © 2025 Datasite